Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

56 results found.

Example of search result explained

Hyrimoz (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Sandoz Canada Inc (Sandoz)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,2 mL) DIN : 2542315
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2542323
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 2542358
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 2505258
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2492164

Hadlima PushTouch (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Organon Canada Inc. (Organon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2533480
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2473100

Hadlima (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Organon Canada Inc. (Organon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2533472
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2473097

Hyrimoz (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Sandoz Canada Inc (Sandoz)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2542331
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 2542366
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2492156

Simlandi (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2523949
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 2523965

Simlandi (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2523957

Yuflyma (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2523760
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 2535076

Yuflyma (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2523779
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 2535084

Abrilada (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Pfizer Canada Inc. (Pfizer)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 2511061
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2511053

Amgevita (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Amgen Canada Inc. (Amgen)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 2459310
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2459299
Page 1 of 6

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.